Dr. Benoit Mulsant is Clinician Scientist in the Campbell Family Mental Health Research Institute at CAMH, and Chair of the Department of Psychiatry in the Faculty of Medicine at the University of Toronto.
Areas of Research
Dr. Mulsant has been designing and conducting clinical trials for “hard-to-treat” older patients with mood disorders for more than 15 years. He is concerned about the demographics of an aging population and the urgency to improve the treatment of seniors with severe mental disorders. He is one of the principal investigators of two major studies: a large placebo-controlled study to investigate the efficacy and tolerability of a combination of a newer antidepressant and an atypical antipsychotic for the treatment of psychotic depression; and the first randomized clinical trial to investigate the efficacy and tolerability of drug therapy for bipolar disorder in late life. In addition, Dr. Mulsant is assessing the nature and course of cognitive impairment in older patients with a psychiatric disorder. He is also involved with a pilot project that uses PET imaging to investigate how to improve the treatment of late-life schizophrenia.
View Dr. Mulsant's publications on Google Scholar.